Summary Polyunsaturated fatty acids (PUFAs) have been implicated in tumour development and have been shown to influence cell proliferation in vitro. We report here that n-3 and n-6 PUFAs at concentration > 10 gM inhibited the proliferation of a human kidney epithelial cell line (2IHKE), which has retained phenotypic characteristics of normal kidney epithelial cells. In contrast, the proliferation was stimulated by n-3 and n-6 PUFAs at concentrations <10 gM under defined growth conditions. The stimulatory effect of n-3 and n-6 PUFAs was even more profound in the presence of EGF. In human kidney epithelial cell lines reflecting different stages of transformation (1IHKE and ITHKEras), the stimulatory effect was abrogated both in the presence and absence of EGF. Saturated fatty acids did not show any stimulatory effect on cell growth. The tyrosine kinase inhibitors genistein and tyrphostin-47 inhibited EGF-induced protein tyrosine phosphorylation dose-dependently in the 2IHKE cells, and abolished the growth stimulatory effect of docosahexaenoic acid (DHA). This indicates the involvement of EGF receptor tyrosine kinase activity in the observed increase in cell proliferation.
Evidence from epidemiological studies suggests that dietary fat may affect the aetiology of cancer, notably breast cancer (Howe et al., 1991) and colorectal cancer (Miller et al., 1983; Nicholson et al., 1988) . Polyunsaturated fatty acids (PUFAs) of the n-6 class have in animal models been shown to increase chemically induced tumour development, possibly by affecting mainly post-initiation stages. Also the growth of transplant tumours may be enhanced by n-6 PUFAs (Reddy and Maruyama, 1986; Cave, 1991; Reddy et al., 1991; . In contrast, n-3 PUFAs have frequently been shown to inhibit tumour development in experimental studies (Karmali et al., 1984; O'Connor et al., 1989; de Bravo et al., 1991; Mtehle et al., 1995) . This has been supported in a human study on fish diet (rich in n-3 PUFAs) and breast cancer rates (Kaizer et al., 1989) . In vitro, the inhibitory effect of PUFAs on cell proliferation has been well documented (Morisaki et al., 1982; Begin et al., 1986; Rose and Connolly, 1991; H0stmark and Lystad, 1992; Krokan et al., 1993; Mzehle et al., 1995) .
The mechanisms involved in modulation of tumour development by PUFAs are unknown. Lipid peroxidation, however, is considered a major contributing factor (reviewed in Gonzalez, 1992) , which is supported by the observation that antioxidants may abolish the growth-inhibitory effect of PUFAs (H0stmark and Lystad, 1992) . The differential effect of n-6 and n-3 PUFAs on tumour development has been explained by increased production of peroxidation products with increasing chain length or degree of unsaturation of the fatty acids, correlating grossly with PUFA classes (Begin, 1989; H0stmark and Lystad, 1992; Krokan et al., 1993) . In addition, exposure to n-6 PUFAs promotes increased synthesis of arachidonic acid-derived cyclooxygenase-and lipoxygenase-catalysed eicosanoids, which in turn may stimulate tumour cell growth (Carter et al., 1983; Noguchi et al., 1993 Noguchi et al., , 1995 . On the contrary, n-3 fatty acids inhibit both the cyclooxygenase and the lipoxygenase pathways (Culp et al., 1979; Corey et al., 1983; Karmali, 1987) . Also gene expression and growth factor-mediated signal transduction may be modulated by fatty acids (Tiwari et al., 1991; Distel et al., 1992; Fazio et al., 1992 The epidermal growth factor (EGF) is involved in growth control of many kinds of cells. EGF binds to the membraneassociated 170 kDa EGF receptor (EGF-R). EGF binding results in receptor dimerisation, thereby activating the intrinsic receptor tyrosine kinase activity, causing its phosphorylation and signal propagation to downstream substrates. Tyrosine kinase activity of the receptor is a prerequisite for EGF-mediated signal transduction (reviewed in Ullrich and Schlessinger, 1990; van der Geer and Hunter, 1994) . EGF-mediated signal transduction may be modulated by PUFAs (Bandyopadhyay et al,. 1987 (Bandyopadhyay et al,. , 1993 Casabiell et al., 1991; Glasgow et al., 1992) .
Recently, we reported a correlation between sensitivity among different cell lines to the growth-inhibitory effect of PUFAs in vitro and the ability of these fatty acids to reduce tumour growth rates in vivo (Krokan et al., 1993; Mxhle et al., 1995) . Little is known about the role of PUFAs on growth factor-mediated signal transduction during in vitro carcinogenesis, especially fatty acids of the n-3 class. We have developed an in vitro human multistep model suitable for human epithelial carcinogenesis studies (Tveito et al 1989; Haugen et al., 1990; Mollerup et al., 1996) . The present study was undertaken to investigate the influence of n-3 [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and n-6 [linoleic acid (LA) al., 1989; Haugen et al., 1990; Mehle et al., 1992) . Recently, we have repeated the nickel-exposure experiment and established a cell line (2IHKE) with several properties of normal kidney epithelial cells. This cell line exhibits EGF-and anchorage-dependence (unpublished results). The kidney epithelial cell lines were cultured in DMEM/F12 (1:1) medium, supplemented with EGF (10 ng ml-1), insulin (5 jug ml), transferrin (5 mg ml-'), hydrocortisone (36 ng ml-1), sodium selenite (5 ng ml-1) and 1% (IIHKE and lTHKEras) or 5% FCS (2IHKE). The cell lines were maintained at 37°C in humidified air containing 5% carbon dioxide.
Stock solutions of fatty acids [free fatty acids: palmitic acid (PA, C16:0), stearic acid (SA, C18:0), linoleic acid (LA, C18:2, n-6), arachidonic acid (ARA, C20:4, n-6), eicosapentaenoic acid (EPA, C20:5, n-3), and docosahexaenoic acid (DHA, C22:6, n-3)] were prepared in 99% ethanol, and stored at -70°C under nitrogen for no longer than a month. After addition of fatty acids, the medium was incubated for 1 h at 37°C in air containing 5% carbon dioxide, before addition to cell cultures. Tyrosine kinase inhibitors (dissolved in dimethyl sulphoxide) were added to cell cultures 1 h before addition of fatty acids and EGF, and were present throughout the incubation period.
DNA synthesis
The proliferative activity of the cells was measured by estimating [3H]thymidine ([3H] TdR) incorporation into DNA, essentially as previously described (Mollerup et al., 1996) . Cells were seeded in 24-well trays, at a density of 1-5 x 104 cells per well in DMEM/F12 medium supplemented with FCS. Two days later the medium was replaced with DMEM/F12 supplemented with 2.25 mg ml-1 fatty acid-free BSA (fraction V) (serum-free medium, SFM) and the indicated concentrations of fatty acids or tyrosine kinase inhibitors (genistein or tyrphostin-47).
[3H]TdR (2.5 mCi ml-l' 1 mCi per well, 82.5 Ci mmol-1 specific activity) was added 48 h later, and incubation continued for 4 h at 37°C. Cells were then fixed in ice-cold methanol for 20 min, followed by three washes in Hepes-buffered saline. Unincorporated [3H]TdR was extracted from the cells by incubation in trichloroacetic acid (5%, w/v) for 20 min at 4°C followed by three washes in water. Cells were lysed in 0.5% sodium dodecyl sulphate (SDS), 0.25 M sodium hydroxide at 60°C for 20 min. Cell lysates were transferred to scintillation vials and radioactivity was measured by liquid scintillation counting. P<0.05, Student's t-test, was considered statistically significant. Experiments were repeated several times with similar results. Parallel experiments with measurement of cell proliferation by cell counting gave similar results (data not shown).
Immunoblotting Cells were seeded in 35 mm dishes as a density of 0.75-1.5
x 105 cells per dish in DMEM/F12 and treated with tyrosine kinase inhibitors as indicated above. Cells were then exposed to 200 ng ml-1 EGF for 5 min at 37°C. The dishes were washed three times in ice-cold Hepes-buffered saline, and cellular proteins were solubilised in SDS-PAGE sample buffer and denatured at 95°C for 5 min (Laemmli, 1970) . Parallel dishes were seeded for determination of protein content by the method of Lowry et al. (1951) .
Proteins were separated on 7.5% SDS-PAGE mini gels (Bio Rad Mini-Protean II, Bio-Rad Laboratories, Richmond, CA, USA) and transferred to Immobilon-P PVDF membranes (Millipore Corporation, Bedford, MA, USA). Tyrosine-phosphorylated proteins were detected with a polyclonal phosphotyrosine-specific antibody (Mollerup et al., 1996) (Mollerup et al., 1996) , were growth inhibited at high concentrations of n-3 PUFAs either in the absence or presence of EGF (Figure lb) . Tumorigenic lTHKEras cells were only slightly inhibited by the fatty acids (Figure lc) The results from Figure 1 indicated a synergistic effect of n-3 PUFAs and EGF on cell proliferation. To study the mechanism(s) involved, the effect of specific inhibitors of tyrosine kinase activity was investigated. 2IHKE cells were incubated in the presence of tyrosine kinase inhibitors at similar conditions to Figure 1 . Cells were then exposed to EGF for 5 min. Cellular extracts were subjected to immunoblotting and probed with a phosphotyrosine-specific antibody. As shown in Figure 2 , a 5 min EGF pulse resulted in tyrosine phosphorylation on the EGF-R and other cellular proteins. Genistein, which is a general inhibitor of tyrosine kinases (Akiyama et al., 1987) , and the relatively specific inhibitor of EGF-R tyrosine kinase activity, tyrphostin-47 (Gazit et al., 1989), inhibited EGF-induced tyrosine phosphorylation dose-dependently. Genistein was a more Figure 2 revealed that the phosphotyrosine content at 25 gM genistein and 50 gM tyrphostin-47 was reduced to 32% and 43% of the controls respectively. Together, these data indicate the involvement of EGF receptor tyrosine kinase in the n-3 PUFA-induced stimulation of 2IHKE cell proliferation.
n-6 PUFAs exert an effect similar to n-3 PUFAs on DNA synthesis in 2IHKE cells The n-6 PUFAs LA and ARA were administered to 2IHKE cells under defined conditions similar to the n-3 fatty acid experiment (Figure 4 ). 
Saturated fatty acids
In contrast to the n-3 and n-6 PUFAs, the saturated fatty acids palmitic and stearic acid did not stimulate proliferation of 2IHKE cells at any concentrations tested ( Figure 5 ). Rather, these fatty acids inhibited cell proliferation in a dosedependent manner, PA being more inhibitory than SA.
Discussion
We report here that low concentrations of n-3 PUFAs stimulated proliferation of the 2IHKE cell line under defined growth conditions. In the presence of EGF, the growthstimulatory effect of PUFAs was even more profound. Specific tyrosine kinase inhibitors [genistein and tyrphostin- 47 (Akiyama et al., 1987; Gazit et al., 1989) ] inhibited EGFinduced protein tyrosine phosphorylation. In addition, genistein and tyrphostin-47 totally abrogated the growthstimulatory effect of DHA, both in the absence or presence of EGF, suggesting interaction with tyrosine kinase signal transduction pathways especially involving the EGF-R. This is in agreement with the reported findings that an EGF-Rblocking antibody caused suppression of LA-stimulated proliferation of a human prostate cancer cell line (DU145M) in serum-free medium (Connolly and Rose, 1992) . The possibility that other factors involved in the growth control of the 2IHKE cells may be affected by genistein and tyrphostin-47, however, cannot be excluded. n-6 and n-9 PUFAs have been reported to inhibit PDGF receptor tyrosine kinase activity in both intact cells and membrane preparations (Tomaska and Resnick, 1993) . Treatment of the 2IHKE cells with n-3 PUFAs at growth-stimulatory conditions (in the absence of EGF) did not affect the EGFinduced level of cellular tyrosine phosphorylation (data not shown). PUFAs have been shown to modulate EGF-mediated signal transduction (Bandyopadhyay et al., 1987 (Bandyopadhyay et al., , 1993 Casabiell et al., 1991) . These studies included fatty acids of the n-6, n-7 and n-9 classes. However, studies on the action of n-3 PUFAs on signal transduction are limited, although modulation of the catalytic activity of protein kinase C and type I cAMP-dependent protein kinase has been demonstrated (Speizer et al., 1991) .
Interestingly, we observed a similar growth-stimulatory effect of low concentrations of both n-3 and n-6 PUFAs on 2IHKE cells, which have retained several phenotypical features of normal cells. Studies have shown that human prostate (PC-3) and breast (MDA-MB-231) cancer cell lines were growth stimulated by low concentrations of n-6 PUFA (LA) under defined conditions. However, in contrast to our results low concentrations of the n-3 PUFAs, EPA and DHA were growth inhibitory Connolly, 1990, 1991) . LA and ARA also stimulated cell proliferation of murine colon adenocarcinomas (Hussey and Tisdale, 1994) . Perfusion of Morris hepatomas (7288CTC) in situ with donor whole blood containing added PUFAs resulted in an increased (n-6) or decreased (n-3) rate of DNA synthesis (Sauer and Dauchy, 1992) . The increase in DNA synthesis rate was observed at high plasma concentrations of n-6 PUFAs (200-600 gM). In vivo studies have shown that PUFAs of the n-6 class may enhance both chemically induced and transplanted tumour development and that PUFAs of the n-3 class frequently exert (Gonzalez et al., 1993; Noguchi et al., 1995) . Our short-term studies on growth-regulatory control by PUFAs does not account for long-term in vivo effects, and a clear correlation between in vivo and in vitro data can therefore not be expected.
The stimulatory effect of the n-3 and n-6 PUFAs was confined to the 2IHKE cell line, which shows apparent normal EGF-mediated growth-regulatory control (unpublished data). In general, PUFAs have been implicated in promotion stages of carcinogenesis (Aylsworth et al., 1984; Reddy et al., 1991; Ronai et al., 1991) . Our data on the action of low concentrations of PUFAs are consistent with a multistep carcinogenesis model where stimulation of clonogenic growth of initiated cells (2IHKE) will enhance the possibility of a hit by secondary carcinogens, and this in turn may result in tumorigenic conversion. The growth-stimulatory effect of PUFAs correlates with normal EGF growthregulatory control. In our in vitro model, the 1IHKE and lTHKEras cell lines showed a marked loss of stimulatory response to low concentrations of PUFAs, indicating an alteration taking place during the in vitro carcinogenic process. These results correlate with our previous observations that the 1IHKE and lTHKEras cell lines have abrogated normal growth-regulatory control in respect of mitogenic response to EGF and expression of the EGF-R (Mollerup et al., 1996) . The proliferation of normal cells is a highly regulated process, controlled by the interplay of growth-inducing and growth-inhibitory signals. Although normal human kidney epithelial cells are stimulated by PUFAs in vitro (data not shown), this characteristic might not be expressed in vivo, indicating no conflict with the perception of PUFAs functioning as tumour promoters.
Using defined growth conditions, we observed an increased resistance towards the growth-inhibitory effect of high concentrations of DHA with increased transformation/ malignant potential of the human kidney epithelial cell lines (2IHKE< lIHKE< lTHKEras). Sensitivity to the growthinhibitory effect of PUFAs varies considerably between different cell types (Krokan et al., 1993; Mxhle et al., 1995) . In contrast to the data presented here, it has been reported that normal cells may be more resistant to the inhibitory effect than tumour cells in vitro (Begin et al., 1986; Krokan et al., 1993) , and it might be expected that sensitivity should increase during development of the transformed phenotype within cell lines with a common origin.
In conclusion, we have shown that n-3 and n-6 fatty acids may stimulate the proliferation of immortalised human kidney epithelial cells with apparent normal EGF growthregulatory control. This effect apparently involves EGF-R tyrosine kinase activity. Furthermore, our results demonstrate that the stimulatory growth response to the PUFAs was abrogated during in vitro transformation of the cell lines. Further studies are needed to determine the specific mechanism(s) involved. Abbreviations EGF, epidermal growth factor; EGF-R, epidermal growth factor receptor; PA, palmitic acid (C16:0); SA, stearic acid (C18:0); LA, linoleic acid (C18:2, n-6); ARA, arachidonic acid (C20:4, n-6); EPA, eicosapentaenoic acid (C20:5, n-3); DHA, docosahexaenoic acid (C22:6, n-3); PUFA, polyunsaturated fatty acid; TdR, thymidine.
